Taiwan The latest pharma news from Taiwan, including Gongwin-KY’s lung cancer drug approval in China, Anxo Pharmaceutical/Genovior Biotech alliance, Taiwan’s Industrial Technology Research Institute (ITRI) and Metagone Biotech’s glaucoma and macular degeneration drug development, and Ever Supreme Bio Technology’s cell therapy progress. New Gongwin-KY lung cancer drug cleared for marketing…
Taiwan Ko-Chung Lin, founder and CEO of PharmaEssentia, documents the main specificities of the company’s groundbreaking ropeginterferon alfa-2b, a once-every-two-week interferon displaying a unique toxicity profile. In this regard, Mr. Lin also provides insights into PharmaEssentia’s approach to the upcoming launch of this product into the US market as well as…
PharmaEssentia When you created PharmaEssentia, what was the rationale behind coming back to Taiwan? The foundation for the company was laid in 1997. A group of Taiwanese government officials came to visit the Boston area at that time, and I helped to arrange them to visit a few biotech companies, and…
See our Cookie Privacy Policy Here